2016
DOI: 10.1002/chem.201504800
|View full text |Cite
|
Sign up to set email alerts
|

New RuII Complex for Dual Activity: Photoinduced Ligand Release and 1O2 Production

Abstract: The new complex [Ru(pydppn)(biq)(py)]2+ (1) undergoes both py photodissociation in CH3CN with Φ500=0.0070(4) and 1O2 production with ΦΔ=0.75(7) in CH3OH from a long-lived 3ππ* state centered on the pydppn ligand (pydppn=3-(pyrid-2-yl)benzo[i]dipyrido[3,2-a:2′,3′-c]phenazine; biq = 2,2′-biquinoline; py= pyridine). This represents an order of magnitude decrease in the Φ500 compared to the previously reported model compound [Ru(tpy)(biq)(py)]2+ (3) (tpy=2,2′:6′,2″-terpyridine) that undergoes only ligand exchange.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

2
50
0
1

Year Published

2016
2016
2018
2018

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 58 publications
(53 citation statements)
references
References 37 publications
2
50
0
1
Order By: Relevance
“…132 The utility of these complexes for these applications relies on their relatively strong absorption and emission intensity in the visible region, long-lived triplet metal-to-ligand charge transfer ( 3 MLCT) excited state lifetimes, and high stability under various experimental conditions. 133 In contrast, the efficient photoinduced ligand dissociation for the release of drugs or biological probes with spatiotemporal control necessitates the population of the dissociative metal-centered, ligand field states ( 3 LF), known to lead to nonradiative deactivation of the emissive 3 MLCT state.…”
Section: Introductionmentioning
confidence: 99%
“…132 The utility of these complexes for these applications relies on their relatively strong absorption and emission intensity in the visible region, long-lived triplet metal-to-ligand charge transfer ( 3 MLCT) excited state lifetimes, and high stability under various experimental conditions. 133 In contrast, the efficient photoinduced ligand dissociation for the release of drugs or biological probes with spatiotemporal control necessitates the population of the dissociative metal-centered, ligand field states ( 3 LF), known to lead to nonradiative deactivation of the emissive 3 MLCT state.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, ruthenium complexes such as [Ru(tpy)(bpy)(L)] 2+ are photochemically active because visible‐light irradiation leads to ligand‐exchange reactions that do not occur in the dark . Such photosubstitution reactions have been proposed as a way to trigger the toxicity of anticancer metallodrugs with spatial and temporal resolution . Likewise, photosubstitution of the protecting monodentate ligand L in [Ru(tpy)(bpy)(L)] 2+ may activate the complex by producing [ 1 ] 2+ inside a cell.…”
Section: Introductionmentioning
confidence: 99%
“…In a process called "photoactivated chemotherapy" (PACT) [1][2][3][4][5], excitation with visible light transforms these non-toxic compounds into cytotoxic species via photosubstitution reactions. Like in photodynamic therapy (PDT), ruthenium-based PACT agents may greatly reduce undesired side effects for cancer patients by the excellent spatio-temporal control over activation.…”
Section: Introductionmentioning
confidence: 99%